Phenylethylidenehydrazine
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (1E)-(2-Phenylethylidene)hydrazine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Uncontrolled |
| Pharmacokinetic data | |
| Half-life | ~12 hours |
| Identifiers | |
| CAS number | 29443-41-2 |
| ATC code | None |
| PubChem | CID 10103216 |
| ChemSpider | 8278744 |
| Chemical data | |
| Formula | C8H10N2 |
| Mol. mass | 134.18 g/mol |
|
|
Phenylethylidenehydrazine (PEH) is an inhibitor of the enzyme GABA transaminase (GABA-T).[1][2] It is a metabolite of the antidepressant phenelzine and is responsible for its elevation of GABA concentrations.[1] PEH likely plays a significant role in phenelzine's high efficacy in treating anxiety disorders.
See also [edit]
References [edit]
- ^ a b Parent MB, Master S, Kashlub S, Baker GB (January 2002). "Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum". Biochemical Pharmacology 63 (1): 57–64. doi:10.1016/S0006-2952(01)00856-5. PMID 11754874.
- ^ Duffy S, Nguyen PV, Baker GB (2004). "Phenylethylidenehydrazine, a novel GABA-transaminase inhibitor, reduces epileptiform activity in rat hippocampal slices". Neuroscience 126 (2): 423–32. doi:10.1016/j.neuroscience.2004.03.007. PMID 15207360.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||
